Biotek-snakken — Januar 2023
-
FDA Approves Eisai And Biogen's Leqembi For Alzheimer's Disease Treatment https://www.proinvestor.com/investornyt/924335/fda-approves-eisai-and-biogens-leqembi-for-alzheimers-disease-treatment
-
Eisai Submits SBLA To FDA For Traditional Approval Of Leqembi For Alzheimer's Disease Treatment https://www.proinvestor.com/investornyt/924336/eisai-submits-sbla-to-fda-for-traditional-approval-of-leqembi-for-alzheimers-disease-treatment
-
Lidt håb til Curevac i sidste uge https://finance.yahoo.com/news/curevac-n-v-nasdaq-cvac-120311976.html
-
2 Healthcare Stocks That Could Make You Richer
-
Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc
Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc - Transaction expands Chiesi’s rare disease medicine portfolio - All cash acquisition at US$14.50 per ADS, plus Contingent Value Rights of up to an additional US$2.50 per ADS based on certain Filsuvez® milestones being achieved - Total Transaction value of up to US$1.48 Billion with upfront consideration representing a 107% premium to Amryt ADS’ closing price on January 6, 2023 - Transaction unanimously approved and recommended by the Boards
Yahoo Finance (finance.yahoo.com)
-
Onxeo + 340 % år til dato
Lækkert med en dobbelt op på en pæn portion left overs fra Chiasma (som jo gik bort alt for tidligt) - håber flere er med her Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind